Document:

Exhibit 10.45

       

      Janel Corporation

       

      AMENDED AND RESTATED

       

      2017 Equity Incentive Plan

       

      (As Amended Through September 21, 2021)

       

      1.            Purposes.

       

      (a)           Eligible Stock Award Recipients.  The persons eligible to receive Stock Awards are Employees,
        Directors and Consultants.

       

      (b)          Available Stock Awards.  The purpose of the Plan is to provide a means by which eligible recipients of
        Stock Awards may be given an opportunity to benefit from increases in value of the Common Stock through the granting of the following Stock Awards: (i) Non-statutory Stock Options, (ii) Restricted Stock Awards, and (iii) Stock Appreciation Rights.

       

      (c)          General Purpose.  The Company, by means of the Plan, seeks to retain the services of the group of
        persons eligible to receive Stock Awards, to secure and retain the services of new members of this group and to provide incentives for such persons to exert maximum efforts for the success of the Company and its Affiliates.

       

      2.            Definitions.

       

      As used in this Plan, the following terms have the following meanings:

       

      (a)         “Affiliate” means, at the time of determination, any parent corporation or
        subsidiary corporation of the Company as those terms are defined in Sections 424(e) and (f), respectively, of the Code.

       

      (b)          “Board” means the Board of Directors of the Company.

       

      (c)          “Capitalization Adjustment” has the meaning ascribed to that term in Section
        11(a).

       

      (d)          “Change in Control” means the occurrence, in a single transaction or in a series
        of related transactions, of any one or more of the following events:

       

      
        1

        
          

      

      (i)          any Exchange Act Person other than a Permitted Holder becomes the Owner, directly or indirectly, of securities of the
        Company representing more than fifty percent (50%) of the combined voting power of the Company’s then outstanding securities other than by virtue of a merger, consolidation or similar transaction.  Notwithstanding the foregoing, a Change in Control
        shall not be deemed to occur (A) on account of the acquisition of securities of the Company by any institutional investor, or any affiliate thereof or any other Exchange Act Person that acquires the Company’s securities in a transaction or series
        of related transactions that are primarily a private financing transaction for the Company or (B) solely because the level of Ownership held by any Exchange Act Person (the “Subject Person”) exceeds the designated percentage threshold of the
        outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence)
        as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred,
        increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control shall be deemed to occur;

       

      (ii)         there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company if,
        immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own, directly or indirectly, either (A) outstanding voting securities representing more than
        fifty percent (50%) of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B) more than fifty percent (50%) of the combined outstanding voting power of the parent of the surviving
        Entity in such merger, consolidation or similar transaction; provided, however, that such transaction will not constitute a Change in Control if more than 50% of the combined voting power of the surviving Entity is held by Permitted
        Holders;

       

      (iii)        individuals who, on the date this Plan is adopted by the Board, are members of the Board (the “Incumbent Board”) cease for
        any reason to constitute at least a majority of the members of the Board; provided, however, that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members of
        the Incumbent Board then still in office, such new member shall, for purposes of this Plan, be considered as a member of the Incumbent Board.; or

       

      (iv)        there is consummated a sale, lease, license or other disposition of all or substantially all of the consolidated assets of
        the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to a Permitted Holder or to an Entity, more than fifty percent (50%)
        of the combined voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the Company immediately prior to such sale, lease, license or other disposition.

       

      The term Change in Control shall not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company.

       

      Notwithstanding the foregoing or any other provision of this Plan, the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any
        Affiliate and the Participant shall supersede the foregoing definition with respect to Stock Awards subject to such agreement (it being understood, however, that if no definition of Change in Control or any analogous term is set forth in such an
        individual written agreement, the foregoing definition shall apply).

       

      
        2

        
          

      

      (e)           “Code” means the Internal Revenue Code of 1986, as amended.

       

      (f)           “Committee” means a committee of one or more members of the Board appointed by
        the Board in accordance with Section 3(c).

       

      (g)          “Common Stock” means the Common Stock of the Company.

       

      (h)          “Company” means Janel Corporation, a Nevada corporation.

       

      (i)         “Consultant” means any person, including an advisor, (i) engaged by the Company or
        an Affiliate to render consulting or advisory services and who is compensated for such services or (ii) serving as a member of the Board of Directors of an Affiliate and who is compensated for such services.  However, the term “Consultant” shall
        not include Directors who are not compensated by the Company for their services as Directors, and the payment of a director’s fee by the Company for services as a Director shall not cause a Director to be considered a “Consultant” for purposes of
        the Plan.

       

      (j)           “Continuous Service” means that the Participant’s service with the Company or an
        Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated.  A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee,
          Consultant or Director or a change in the entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant’s service with the Company or an Affiliate, shall not terminate a
          Participant’s Continuous Service.  For example, a change in status from an employee of the Company to a consultant to an Affiliate or to a Director shall not constitute an interruption of Continuous Service.  The Board or the chief executive
          officer of the Company, in that party’s sole discretion, may determine whether Continuous Service shall be considered interrupted in the case of any leave of absence approved by that party, including sick leave, military leave or any other
          personal leave.  Notwithstanding the foregoing, a leave of absence shall be treated as Continuous Service for purposes of vesting in a Stock Award only to such extent as may be provided in the Company’s leave of absence policy or in the written
          terms of the Participant’s leave of absence.

       

      (k)          “Corporate Transaction” means the occurrence, in a single transaction or in a
        series of related transactions, of any one or more of the following events:

       

      (i)           a sale or other disposition of all or substantially all, as determined by the
        Board in its discretion, of the consolidated assets of the Company and its Subsidiaries;

       

      (ii)          a sale or other disposition of at least fifty percent (50%) of the outstanding securities of the Company;

       

      
        3

        
          

      

      (iii)       a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or (iv) a
        merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by
        virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.

       

      (l)            “Director” means a member of the Board.

       

      (m)          “Disability” means the permanent and total disability of a person within the
        meaning of Section 22(e)(3) of the Code.

       

      (n)          “Employee” means any person employed by the Company or an Affiliate.  Service as
        a Director or payment of a director’s fee by the Company for such service or for service as a member of the Board of Directors of an Affiliate shall not be sufficient to constitute “employment” by the Company or an Affiliate.

       

      (o)          “Entity” means a corporation, partnership, limited liability company, trust or
        other entity.

       

      (p)          “Exchange Act” means the Securities Exchange Act of 1934, as amended.

       

      (q)        “Exchange Act Person” means any natural person, Entity or “group” (within the
        meaning of Section 13(d) or 14(d) of the Exchange Act), except that “Exchange Act Person” shall not include (A) the Company or any Subsidiary of the Company, (B) any employee benefit plan of the Company or any Subsidiary of the Company or any
        trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (C) an underwriter temporarily holding securities pursuant to an offering of such
          securities, or (D) an Entity owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company.

       

      (r)          “Fair Market Value” means, as of any date, the value of the Common Stock
        determined in good faith by the Board and in accordance with Section 409A of the Code and applicable guidance thereunder.

       

      (s)          “Incentive Stock Option” means an Option intended to qualify as an incentive
        stock option within the meaning of Section 422 of the Code and the regulations promulgated thereunder.

       

      (t)          “Listing Date” means the first date upon which any security of the Company is
        listed (or approved for listing) upon notice of issuance on any securities exchange or designated (or approved for designation) upon notice of issuance as a national market security on an interdealer quotation system.

       

      (u)          “Non-statutory Stock Option” means an Option not intended to qualify as an
        Incentive Stock Option.

       

      (v)          “Officer” means any person designated by the Company as an officer.

       

      
        4

        
          

      

      (w)          “Option” means a Non-statutory Stock Option granted pursuant to the Plan.

       

      (x)         “Option Agreement” means a written agreement between the Company and an
        Optionholder evidencing the terms and conditions of an individual Option grant.  Each Option Agreement shall be subject to the terms and conditions of the Plan; provided, however, that an Option Agreement may contain terms that vary from the terms
        of the Plan.

       

      (y)         “Optionholder” means a person to whom an Option is granted pursuant to the Plan
        or, if applicable, such other person who holds an outstanding Option.

       

      (z)          “Own,” “Owned,” “Owner,” “Ownership” A
        person or Entity shall be deemed to “Own,” to have “Owned,” to be the “Owner” of, or to have acquired “Ownership” of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or
        otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.

       

      (aa)         “Participant” means a person to whom a Stock Award is granted pursuant to the
        Plan or, if applicable, such other person who holds an outstanding Stock Award.

       

      (bb)        “Permitted Holder” means Oaxaca Group L.L.C., Dominique Schulte or any of their
        respective Affiliates.

       

      (cc)         “Plan” means this Janel Corporation Amended and Restated 2017 Equity Incentive
        Plan, as amended from time to time.

       

      (dd)        “Restricted Stock Award” means an award of shares of Common Stock which is
        granted pursuant to the terms and conditions of Section 7(a).

       

      (ee)        “Securities Act” means the Securities Act of 1933, as amended.

       

      (ff)         “Stock Appreciation Right” means a right to receive the appreciation on Common
        Stock that is granted pursuant to the terms and conditions of Section 7(b).

       

      (gg)       “Stock Award” means any right granted under the Plan, including an Option, a
        Restricted Stock Award and a Stock Appreciation Right.

       

      (hh)       “Stock Award Agreement” means a written agreement between the Company and a holder
        of a Stock Award evidencing the terms and conditions of an individual Stock Award grant.  Each Stock Award Agreement shall be subject to the terms and conditions of the Plan.

       

      (ii)         “Subsidiary” means, with respect to the Company, (i) any corporation of which
        more than fifty percent (50%) of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such
        corporation shall have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii) any partnership in which the Company has a direct or indirect interest (whether
        in the form of voting or participation in profits or capital contribution) of more than fifty percent (50%).

       

      
        5

        
          

      

      3.             Administration.

       

      (a)        Administration by Board.  The Board shall administer the Plan unless and until the Board delegates
        administration to a Committee, as provided in Section 3(c).

       

      (b)           Powers of Board.  The Board shall have the power, subject to, and within the limitations of, the
        express provisions of the Plan:

       

      (i)           To determine from time to time which of the persons eligible under the Plan shall be granted Stock Awards; when and how
        each Stock Award shall be granted; what type or combination of types of Stock Award shall be granted; the provisions of each Stock Award granted (which need not be identical), including the time or times when a person shall be permitted to receive
        Common Stock pursuant to a Stock Award; and the number of shares of Common Stock with respect to which a Stock Award shall be granted to each such person.

       

      (ii)         To construe and interpret the Plan and Stock Awards granted under it, and to establish, interpret, amend and revoke rules
        and regulations for its administration.  The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in any Stock Award Agreement, in a manner and to the extent it shall deem necessary or expedient to
        make the Plan fully effective.

       

      (iii)         To effect, at any time and from time to time, with the consent of any adversely affected Optionholder, (1) the reduction
        of the exercise price of any outstanding Option under the Plan, (2) the cancellation of any outstanding Option under the Plan and the grant in substitution therefor of (A) a new Option under the Plan or another equity plan of the Company covering
        the same or a different number of shares of Common Stock, (B) a Restricted Stock Award (including a stock bonus), (C) a Stock Appreciation Right, (D) cash and/or (E) other valuable consideration (as determined by the Board, in its sole discretion),
        or (3) any other action that is treated as a repricing under generally accepted accounting principles.

       

      (iv)          To amend the Plan or a Stock Award as provided in Section 12.

       

      (v)           To terminate or suspend the Plan as provided in Section 13.

       

      (vi)        To approve forms of Stock Award Agreements for use under the Plan and to amend the terms of any one or more Stock Awards,
        including, but not limited to, amendments to provide terms more favorable than previously provided in the Stock Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; provided however, that, the rights under any Award shall not be materially impaired by any such amendment unless (i) the Company requests the consent of the affected Participant, and (ii) such
          Participant consents in writing.

       

      
        6

        
          

      

      (vii)        Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best
        interests of the Company and that are not in conflict with the provisions of the Plan.

       

      (c)           Delegation to Committee.  The Board may delegate administration of the Plan to a Committee or
        Committees of one (1) or more members of the Board, and the term “Committee” shall apply to any person or persons to whom such authority has been delegated.  If administration is delegated to a Committee, the Committee shall have, in connection
        with the administration of the Plan, the powers theretofore possessed by the Board, including the power to delegate to a subcommittee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board
        shall thereafter be to the Committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board.  The Board may abolish the Committee at any time and
        revest in the Board the administration of the Plan.

       

      (d)          Effect of Board’s Decision.  All determinations, interpretations and constructions made by the Board
        in good faith shall not be subject to review by any person and shall be final, binding and conclusive on all persons.

       

      4.            Shares Subject to the Plan.

       

      (a)          Share Reserve.  Subject to the provisions of Section 11(a) relating to Capitalization Adjustments,
        the Common Stock that may be issued pursuant to Stock Awards shall not exceed in the aggregate 200,000 shares.

       

      (b)          Reversion of Shares to the Share Reserve.  If any Stock Award shall for any reason expire or
        otherwise terminate, in whole or in part, without having been exercised in full, or if any shares of Common Stock issued to a Participant pursuant to a Stock Award are forfeited back to or repurchased by the Company, including, but not limited to,
        any repurchase or forfeiture caused by the failure to meet a contingency or condition required for the vesting of such shares, then the shares of Common Stock not acquired under such Stock Award shall revert to and again become available for
        issuance under the Plan.  If any shares subject to a Stock Award are not delivered to a Participant because such shares are withheld for the payment of taxes, then the number of shares that are not delivered shall revert to and again become
        available for issuance under the Plan.  If the exercise price of any Stock Award is satisfied by tendering shares of Common Stock held the Participant (either by actual deliver or attestation), then the number of such tendered shares shall revert
        to and again become available for issuance under the Plan.

       

      (c)          Source of Shares.  The shares of Common Stock subject to the Plan may be unissued shares or reacquired
        shares, bought on the market or otherwise.

       

      5.            Eligibility.

       

      (a)           Eligibility for Specific Stock Awards. Stock Awards may be granted to Employees, Directors and Consultants.

       

      
        7

        
          

      

      (b)           Consultants.  A Consultant shall not be eligible for the grant of a Stock Award if, at the time of
        grant, either the offer or the sale of the Company’s securities to such Consultant is not exempt because of the nature of the services that the Consultant is providing to the Company, because the Consultant is not a natural person, or because of
        some other provision of the law.

       

      6.            Option Provisions.

       

      Each Option shall be in such form and shall contain such terms and conditions as the Board shall deem appropriate.  All Options granted hereunder shall be Non-statutory Stock Options , and, if
        certificates are issued, a separate certificate or certificates shall be issued for shares of Common Stock purchased on exercise of the Option.  The provisions of separate Options need not be identical, but each Option shall include (through
        incorporation of provisions hereof by reference in the Option or otherwise) the substance of each of the following provisions:

       

      (a)           Term.  No Option granted shall be exercisable after the expiration of ten (10) years from the date
        on which it was granted.

       

      (b)          Exercise Price of a Stock Option.  The exercise price of each Option shall be not less than one
        hundred percent (100%) of the Fair Market Value of the Common Stock subject to the Option on the date the Option is granted.  Notwithstanding the foregoing, an Option may be granted with an exercise price lower than that set forth in the preceding
        sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Sections 409A of the Code.

       

      (c)          Consideration.  The purchase price of Common Stock acquired pursuant to an Option shall be paid, to
        the extent permitted by applicable statutes and regulations, either (i) by cash, check, bank draft or money order payable to the Company at the time the Option is exercised or (ii) at the discretion of the Board at the time of the grant of the
        Option (or subsequently in the case of a Non-statutory Stock Option) (1) by delivery to the Company of other Common Stock, or (2) pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the
        issuance of Common Stock, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instruction to pay the aggregate exercise price to the Company from the sales proceeds, or (3) in any other form of legal
        consideration (including, without limitation, net settlement in shares of Common Stock) that may be acceptable to the Board.

       

      (d)           Transferability of a Non-statutory Stock Option.  A Non-statutory Stock Option shall be transferable
        to the extent provided in the Option Agreement.  If the Non-statutory Stock Option does not provide for transferability, then the Non-statutory Stock Option shall not be transferable except by will or by the laws of descent and distribution and
        shall be exercisable during the lifetime of the Optionholder only by the Optionholder.  Notwithstanding the foregoing, (i) the Optionholder may, by delivering written notice to the Company, in a form satisfactory to the Company, designate a third
        party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise the Option, and (ii) the Board may, in its sole discretion, permit transfer of a Non-statutory Stock Option in a manner consistent with applicable
        tax and securities laws upon the Optionholder’s request.

       

      
        8

        
          

      

      (e)         Vesting Generally.  The total number of shares of Common Stock subject to an Option may, but need not,
        vest and therefore become exercisable in periodic installments that may, but need not, be equal.  The Option may be subject to such other terms and conditions on the time or times when it may be exercised (which may be based on performance or other
        criteria) as the Board may deem appropriate.  The vesting provisions of individual Options may vary.  The provisions of this Section 6(f) are subject to any Option provisions governing the minimum number of shares of Common Stock as to which an
        Option may be exercised.

       

      (f)         Termination of Continuous Service.  Except as otherwise provided in the applicable Stock Award
        Agreement or other agreement between the Company and the Optionholder, in the event that an Optionholder’s Continuous Service terminates (other than upon the Optionholder’s death or Disability), the Optionholder may exercise his or her Option (to
        the extent that the Optionholder was entitled to exercise such Option as of the date of termination) but only within such period of time ending on the earlier of (i) the date three (3) months following the termination of the Optionholder’s
        Continuous Service (or such longer or shorter period specified in the Option Agreement), or (ii) the expiration of the term of the Option as set forth in the Option Agreement.  If, after termination, the Optionholder does not exercise his or her
        Option within the time specified in the Option Agreement, the Option shall terminate.

       

      (g)        Extension of Termination Date.  An Optionholder’s Option Agreement may also provide that if the
        exercise of the Option following the termination of the Optionholder’s Continuous Service (other than upon the Optionholder’s death or Disability) would be prohibited at any time solely because the issuance of shares of Common Stock would violate
        the registration requirements under the Securities Act, then the Option shall terminate on the earlier of (i) the expiration of the term of the Option set forth in Section 6(a) or (ii) the expiration of a period of three (3) months after the
        termination of the Optionholder’s Continuous Service during which the exercise of the Option would not be in violation of such registration requirements.

       

      (h)        Disability of Optionholder.  Except as otherwise provided in the applicable Stock Award Agreement or
        other agreement between the Company and the Optionholder, in the event that an Optionholder’s Continuous Service terminates as a result of the Optionholder’s Disability, the Optionholder may exercise his or her Option (to the extent that the
        Optionholder was entitled to exercise such Option as of the date of termination), but only within such period of time ending on the earlier of (i) the date twelve (12) months following such termination (or such longer or shorter period specified in
        the Option Agreement) or (ii) the expiration of the term of the Option as set forth in the Option Agreement.  If, after termination, the Optionholder does not exercise his or her Option within the time specified herein, the Option shall terminate.

       

      (i)         Death of Optionholder.  Except as otherwise provided in the applicable Stock Award Agreement or other
        agreement between the Company and the Optionholder, in the event that (i) an Optionholder’s Continuous Service terminates as a result of the Optionholder’s death or (ii) the Optionholder dies within the period (if any) specified in the Option
        Agreement after the termination of the Optionholder’s Continuous Service for a reason other than death, then the Option may be exercised (to the extent the Optionholder was entitled to exercise such Option as of the date of death) by the
        Optionholder’s estate, by a person who acquired the right to exercise the Option by bequest or inheritance or by a person designated to exercise the option upon the Optionholder’s death pursuant to Section 6(e) or 6(f), but only within the period
        ending on the earlier of (1) the date eighteen (18) months following the date of death (or such longer or shorter period specified in the Option Agreement) or (2) the expiration of the term of such Option as set forth in the Option Agreement.  If,
        after death, the Option is not exercised within the time specified herein, the Option shall terminate.

       

      
        9

        
          

      

      (j)            Early Exercise.  The Option may, but need not, include a provision whereby the Optionholder may
        elect at any time before the Optionholder’s Continuous Service terminates to exercise the Option as to any part or all of the shares of Common Stock subject to the Option prior to the full vesting of the Option.  Any unvested shares of Common Stock
        so purchased may be subject to a repurchase option in favor of the Company or to any other restriction the Board determines to be appropriate.

       

      (k)           Right of First Refusal.  The Option may, but need not, include a provision whereby the Company may
        elect to exercise a right of first refusal following receipt of notice from the Optionholder of the intent to transfer all or any part of the shares of Common Stock received upon the exercise of the Option.

       

      7.             Provisions of Stock Awards other than Options.

       

        

      (a)           Restricted Stock Awards.  Each Restricted Stock Award agreement shall be in such form and shall
        contain such terms and conditions as the Board shall deem appropriate.  The terms and conditions of Restricted Stock Award agreements may change from time to time, and the terms and conditions of separate Restricted Stock Award agreements need not
        be identical; provided, however, that each Restricted Stock Award agreement shall include (through incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each
        of the following provisions:

       

      (i)           Purchase Price.  At the time of the grant of a Restricted Stock Award, the Board
        will determine the price to be paid by the Participant for each share subject to the Restricted Stock Award. To the extent required by applicable law, the price to be paid by the Participant for each share of the Restricted Stock Award will not be
        less than the par value of a share of Common Stock.  A Restricted Stock Award may be awarded as a stock bonus (i.e., with no cash purchase price to be paid) to the extent permissible under applicable law.

       

      (ii)       Consideration.  At the time of the grant of a Restricted Stock Award, the Board will
        determine the consideration permissible for the payment of the purchase price of the Restricted Stock Award.  The purchase price of Common Stock acquired pursuant to the Restricted Stock Award shall be paid in one of the following ways: (i) in cash
        at the time of purchase; (ii) by services rendered or to be rendered to the Company; or (iii) in any other form of legal consideration that may be acceptable to the Board.

       

      (iii)         Vesting. Shares of Common Stock acquired under a Restricted Stock Award may, but
        need not, be subject to a share repurchase option in favor of the Company in accordance with a vesting schedule to be determined by the Board.

       

      
        10

        
          

      

      (iv)          Termination of Participant’s Continuous Service. In the event that a
        Participant’s Continuous Service terminates, the Company may repurchase or otherwise reacquire any or all of the shares of Common Stock held by the Participant that have not vested as of the date of termination under the terms of the Restricted
        Stock Award agreement.  The Company will not exercise its repurchase option until at least six (6) months (or such longer or shorter period of time required to avoid a charge to earnings for financial accounting purposes) have elapsed following the
        purchase of the restricted stock unless otherwise determined by the Board or provided in the Restricted Stock Award agreement.

       

      (v)         Transferability. Rights to purchase or receive shares of Common Stock granted under
        a Restricted Stock Award shall be transferable by the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award agreement, as the Board shall determine in its discretion, and so long as Common Stock awarded
        under the Restricted Stock Award remains subject to the terms of the Restricted Stock Award agreement.

       

      (b)           Stock Appreciation Rights.  Each Stock Appreciation Right agreement shall be in such form and shall
        contain such terms and conditions as the Board shall deem appropriate.  The terms and conditions of Stock Appreciation Right agreements may change from time to time, and the terms and conditions of separate Stock Appreciation Rights agreements need
        not be identical, but each Stock Appreciation Right agreement shall include (through incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions:

       

      (i)           Term.  No Stock Appreciation Right shall be exercisable after the expiration of
        ten (10) years from the date of its grant or such shorter period specified in the Stock Appreciation Right Agreement.

       

      (ii)          Strike Price.  Notwithstanding anything in the applicable Stock Award Agreement
        to the contrary, the strike price of each Stock Appreciation Right shall not be less than the Fair Market Value of the Common Stock equivalents subject to the Stock Appreciation Right on the date of grant.

       

      (iii)       Calculation of Appreciation.  Each Stock Appreciation Right will be denominated in
        share of Common Stock equivalents.  The appreciation distribution payable on the exercise of a Stock Appreciation Right will be not greater than an amount equal to the excess of (A) the aggregate Fair Market Value (on the date of the exercise of
        the Stock Appreciation Right) of a number of shares of Common Stock equal to the number of share of Common Stock equivalents in which the Participant is vested under such Stock Appreciation Right and with respect to which the Participant is
        exercising the Stock Appreciation Right on such date, over (B) the strike price that is determined by the Committee pursuant to Section 7(b)(ii).

       

      (iv)          Vesting.  At the time of the grant of a Stock Appreciation Right, the Board may
        impose such restrictions or conditions to the vesting of such Right as it deems appropriate.

       

      
        11

        
          

      

      (v)        Exercise.  To exercise any outstanding Stock Appreciation Right, the Participant
        must provide written notice of exercise to the Company in compliance with the provisions of the Stock Appreciation Rights agreement evidencing such Right.

       

      (vi)        Payment. The appreciation distribution in respect of a Stock Appreciation Right may
        be paid in Common Stock, in cash, or any combination of the two, as the Board deems appropriate.

       

      (vii)       Termination of Continuous Service.  If a Participant’s Continuous Service
        terminates for any reason, any unvested Stock Appreciation Rights shall be forfeited and any vested Stock Appreciation Rights shall be automatically redeemed.

       

      8.          Covenants of the Company.

       

      (a)         Availability of Shares.  During the terms of the Stock Awards, the Company shall keep available at all
        times the number of shares of Common Stock required to satisfy such Stock Awards.

       

      (b)          Securities Law Compliance.  A Participant shall not be eligible for the grant of a Stock Award or the
        subsequent issuance of Common Stock pursuant to the Stock Award if such grant or issuance would be in violation of any applicable securities laws.

       

      9.            Use of Proceeds from Stock.

       

      Proceeds from the sale of Common Stock pursuant to Stock Awards shall constitute general funds of the Company.

       

      10.           Miscellaneous.

       

      (a)           Acceleration of Exercisability and Vesting.  The Board shall have the power to accelerate the time
        at which a Stock Award may first be exercised or the time during which a Stock Award or any part thereof will vest in accordance with the Plan, notwithstanding the provisions in the Stock Award stating the time at which it may first be exercised or
        the time during which it will vest.

       

      (b)          Stockholder Rights.  No Participant shall be deemed to be the holder of, or to have any of the rights
        of a holder with respect to, any shares of Common Stock subject to such Stock Award unless and until such Participant has satisfied all requirements for exercise of the Stock Award pursuant to its terms.

       

      (c)         No Employment or other Service Rights.  Nothing in the Plan or any instrument executed or Stock Award
        granted pursuant thereto shall confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Stock Award was granted or shall affect the right of the Company or an Affiliate to
        terminate (i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant to the terms of such Consultant’s agreement with the Company or an Affiliate or (iii) the service of a Director
        pursuant to the Bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be.

       

      
        12

        
          

      

      (d)         Investment Assurances.  The Company may require a Participant, as a condition of exercising or
        acquiring Common Stock under any Stock Award, (i) to give written assurances satisfactory to the Company as to the Participant’s knowledge and experience in financial and business matters and/or to employ a purchaser representative reasonably
        satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that he or she is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the Stock Award;
        and (ii) to give written assurances satisfactory to the Company stating that the Participant is acquiring Common Stock subject to the Stock Award for the Participant’s own account and not with any present intention of selling or otherwise
        distributing the Common Stock.  The foregoing requirements, and any assurances given pursuant to such requirements, shall be inoperative if (1) the issuance of the shares of Common Stock upon the exercise or acquisition of Common Stock under the
        Stock Award has been registered under a then currently effective registration statement under the Securities Act or (2) as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in
        the circumstances under the then applicable securities laws.  The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with
        applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock.

       

      (e)          Withholding Obligations.  To the extent provided by the terms of a Stock Award Agreement, the
        Participant may satisfy any federal, state or local tax withholding obligation relating to the exercise or acquisition of Common Stock under a Stock Award by any of the following means (in addition to the Company’s right to withhold from any
        compensation paid to the Participant by the Company) or by a combination of such means:  (i) tendering a cash payment; (ii) authorizing the Company to withhold shares of Common Stock from the shares of Common Stock otherwise issuable to the
        Participant as a result of the exercise or acquisition of Common Stock under the Stock Award; provided, however, that no shares of Common Stock are withheld with a value exceeding the minimum amount of tax
        required to be withheld by law (or such other amount as may be necessary to avoid variable award accounting); or (iii) delivering to the Company owned and unencumbered shares of Common Stock; or (iv) by such other method as may be set forth in the
        Stock Award Agreement.

       

      (f)          Electronic Delivery.  Any reference herein to a “written” agreement or document shall include any
        agreement or document delivered electronically or posted on the Company’s website.

       

      (g)         Corporate Action Constituting Grant of Stock Awards.  Corporate action constituting a grant by the
        Company of a Stock Award to any Participant shall be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Stock Award is
        communicated to, or actually received or accepted by, the Participant. If the Board determines that the terms of a Stock Award do not reflect the appropriate exercise, strike or purchase price on the appropriate date of grant in accordance with the
        requirements of the Plan, the terms of the Stock Award shall be automatically corrected to reflect the appropriate price or other terms provided for under the Plan, as determined by the Board, without the need for consent of the Participant;
        provided, however , that no such correction shall result in a direct or indirect reduction in the exercise price or strike price of the Stock Award.

       

      
        13

        
          

      

      (h)         Compliance with 409A.  To the extent that the Board determines that any Stock Award granted under the
        Plan is subject to Section 409A of the Code, the Stock Award Agreement evidencing such Stock Award shall incorporate the terms and conditions necessary to avoid the consequences specified in Section 409A(a)(1) of the Code.  To the extent permitted
        by applicable law, the Plan and Stock Award Agreements shall be interpreted in accordance with Section 409A of the Code and Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such
        regulations or other guidance that may be issued or amended after the date the Plan was approved by the Board and stockholders of the Company. Notwithstanding anything in the Plan or in any Stock Award Agreement to the contrary, to the extent that
        any amount or benefit that would constitute non-exempt “deferred compensation” for purposes of the Code would otherwise be payable or distributable under the Plan or any Stock Award Agreement by reason of the occurrence of a Change in Control, or
        Participant’s Disability or separation from service, such amount or benefit will not be payable or distributable to Participant by reason of such circumstance unless (i) the circumstances giving rise to such Change in Control, Disability or
        separation from service meet any description or definition of “change in control event,” “disability” or “separation from service”, as the case may be, in Section 409A of the Code and applicable regulations (without giving effect to any elective
        provisions that may be available under such definition), or (ii) the payment or distribution of such amount or benefit would be exempt from the application of Section 409A of the Code by reason of the short-term deferral exemption or otherwise.
        This provision does not prohibit the vesting of any amount upon a Change in Control, Disability or separation from service, however defined.  If this provision prevents the payment or distribution of any amount or benefit, such payment or
        distribution shall be made on the date, if any, on which an event occurs that constitutes a Section 409A-compliant “change in control event” “disability” or “separation from service” as the case may be.  In addition, to the greatest extent
        permitted by applicable law, the Board may adopt such amendments to the Plan and the applicable Stock Award Agreement (including but not limited to increasing the exercise price of an Award to the extent required for the avoidance of the tax
        consequences set forth in Section 409A(a)(1)) or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Board determines are necessary or appropriate to (i)
        exempt the Stock Award from Section 409A of the Code and/or preserve the intended tax treatment of the benefits provided with respect to the Stock Award, or (ii) comply with the requirements of Section 409A of the Code and related Department of
        Treasury guidance.

       

      
        14

        
          

      

      11.           Adjustments upon Changes in Stock.

       

      (a)           Capitalization Adjustments.  If any change is made in, or other event occurs with respect to, the
        Common Stock subject to the Plan or subject to any Stock Award without the receipt of consideration by the Company (through merger, consolidation, reorganization, recapitalization, reincorporation, stock
          dividend, dividend in property other than cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or other transaction not involving the receipt of consideration by the Company (each a
          “Capitalization Adjustment”), the Plan will be appropriately adjusted in the class(es) and maximum number of securities subject to the Plan pursuant to Sections 4(a) and 4(b) and the outstanding Stock Awards will be appropriately adjusted in the
          class(es) and number of securities and price per share of Common Stock subject to such outstanding Stock Awards.  The Board shall make such adjustments, and its determination shall be final, binding and conclusive.  (The conversion of any
          convertible securities of the Company shall not be treated as a transaction “without receipt of consideration” by the Company).

       

      (b)        Dissolution or Liquidation.  Except as otherwise provided in the Stock Award Agreement, in the event of
        a dissolution or liquidation of the Company, and upon ten (10) days prior written notice, all outstanding Stock Awards shall terminate immediately prior to the completion of such dissolution or liquidation, and shares of Common Stock subject to the
        Company’s repurchase option may be repurchased by the Company notwithstanding the fact that the holder of such stock in still in Continuous Service, provided, however, that the Board may, in its sole
        discretion, cause some or all Stock Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Stock Awards have not previously expired or terminated) before the dissolution or liquidation is
        completed but contingent on its completion.

       

      (c)          Corporate Transaction.  Except as otherwise stated in the Stock Award Agreement, in the event of a
        Corporate Transaction, any surviving corporation or acquiring corporation may assume or continue any or all Stock Awards outstanding under the Plan or may substitute similar stock awards for Stock Awards outstanding under the Plan (it being
        understood that similar stock awards include, but are not limited to, awards to acquire the same consideration paid to the stockholders or the Company, as the case may be, pursuant to the Corporate Transaction), and any reacquisition or repurchase
        rights held by the Company in respect of Common Stock issued pursuant to Stock Awards may be assigned by the Company to the successor of the Company (or such successor’s parent company), if any, in connection with such Corporate Transaction.  A
        surviving corporation or acquiring corporation (or its parent) may choose to assume or continue only a portion of a Stock Award or substitute a similar stock award for only a portion of a Stock Award.  Except as otherwise stated in the Stock Award
        Agreement, in the event that any surviving corporation or acquiring corporation does not assume or continue any or all such outstanding Stock Awards or substitute similar stock awards for such outstanding Stock Awards, then with respect to Stock
        Awards that have not been assumed, continued or substituted and that are held by Participants whose Continuous Service has not terminated prior to the effective time of the Corporate Transaction (“Current Participants”), the vesting of such Stock
        Awards (and, if applicable, the time at which such Stock Awards may be exercised) shall (contingent upon the effectiveness of the Corporate Transaction) be accelerated in full to a date prior to the effective time of such Corporate Transaction as
        the Board shall determine (or, if the Board shall not determine such a date, to the date that is five (5) days prior to the effective time of the Corporate Transaction), the Stock Awards shall terminate if not exercised (if applicable) at or prior
        to such effective time, and any reacquisition or repurchase rights held by the Company with respect to such Stock Awards held by Participants whose Continuous Service has not terminated shall (contingent upon the effectiveness of the Corporate
        Transaction) lapse.  With respect to any other Stock Awards outstanding under the Plan that have not been assumed, continued or substituted that are not held by current Participants, the vesting of such Stock Awards (and, if applicable, the time at
        which such Stock Award may be exercised) shall not be accelerated, unless otherwise provided in a written agreement between the Company or any Affiliate and the holder of such Stock Award, and such Stock Awards, upon advance written notice by the
        Company of at least 10 days to the holders of such Stock Awards,  shall terminate if not exercised (if applicable) prior to the effective time of the Corporate Transaction; provided, however that any
        reacquisition or repurchase rights held by the Company with respect to such Stock Awards shall not terminate and may continue to be exercised notwithstanding the Corporate Transaction.

       

      
        15

        
          

      

      (d)           Change in Control.

       

      (i)           Stock Awards May be Assumed.  Except as otherwise stated in the Stock Award
        Agreement, in the event of a Change in Control, any surviving corporation or acquiring corporation (or the surviving or acquiring corporation’s parent company) may assume or continue any or all Stock Awards outstanding under the Plan or may
        substitute similar stock awards for Stock Awards outstanding under the Plan (including but not limited to, awards to acquire the same consideration paid to the stockholders of the Company pursuant to the Change in Control), and any reacquisition or
        repurchase rights held by the Company in respect of Common Stock issued pursuant to Stock Awards may be assigned by the Company to the successor of the Company (or the successor’s parent company, if any), in connection with such Change in Control.
        A surviving corporation or acquiring corporation (or its parent) may choose to assume or continue only a portion of a Stock Award or substitute a similar stock award for only a portion of a Stock Award.

       

      (ii)          Stock Awards Not Assumed Held by Current Participants.  Except as otherwise
        stated in the Stock Award Agreement, in the event of a Change in Control in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue any or all outstanding Stock Awards or substitute similar stock
        awards for such outstanding Stock Awards, then with respect to Stock Awards that have not been assumed, continued or substituted and that are held by Current Participants, the vesting of such Stock Awards (and, if applicable, the time at which such
        Stock Awards may be exercised) shall (contingent upon the effectiveness of the Change in Control) be accelerated in full to a date prior to the effective time of such Change in Control as the Board shall determine (or, if the Board shall not
        determine such a date, to the date that is five business (5) days prior to the effective time of the Change in Control), and such Stock Awards shall terminate if not exercised (if applicable) at or prior to the effective time of the Change in
        Control, and any reacquisition or repurchase rights held by the Company with respect to such Stock Awards shall lapse (contingent upon the effectiveness of the Change in Control).

       

      
        16

        
          

      

      (iii)        Stock Awards Not Assumed Held by Persons other than Current Participants.  Except
        as otherwise stated in the Stock Award Agreement, in the event of a Change in Control in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue any or all outstanding Stock Awards or substitute
        similar stock awards for such outstanding Stock Awards, then with respect to Stock Awards that have not been assumed, continued or substituted and that are held by persons other than current Participants, the vesting of such Stock Awards (and, if
        applicable, the time at which such Stock Award may be exercised) shall not be accelerated and such Stock Awards (other than a Stock Award consisting of vested and outstanding shares of Common Stock not subject to the Company’s right of repurchase),
        upon advance written notice by the Company of at least 10 days to the holders of such Stock Awards, shall terminate if not exercised (if applicable) prior to the effective time of the Change in Control; provided,
          however, that any reacquisition or repurchase rights held by the Company with respect to such Stock Awards shall not terminate and may continue to be exercised notwithstanding the Change in Control.

       

      (iv)         Additional Provisions.  A Stock Award may be subject to additional acceleration of
        vesting and exercisability upon or after a Change in Control as may be provided in the Stock Award Agreement for such Stock Award or as may be provided in any other written agreement between the Company or any Affiliate and the Participant.  A
        Stock Award may vest as to all or any portion of the shares subject to the Stock Award (i) immediately upon the occurrence of a Change in Control, whether or not such Stock Award is assumed, continued, or substituted by a surviving or acquiring
        entity in the Change in Control, and/or (ii) in the event a Participant’s Continuous Service is terminated, actually or constructively, within a designated period following the occurrence of a Change in Control.

       

      12.           Amendment of the Plan and Stock Awards.

       

      (a)          Amendment of Plan.  The Board at any time, and from time to time, may amend the Plan.

       

      (b)          Stockholder Approval.  The Board, in its sole discretion, may submit any other amendment to the Plan
        for stockholder approval.

       

      (c)         No Impairment of Rights.  Rights under any Stock Award granted before amendment of the Plan shall not
        be impaired by any amendment of the Plan unless (i) the Company requests the consent of the Participant and (ii) the Participant consents in writing.

       

      (d)         Amendment of Stock Awards.  The Board at any time, and from time to time, may amend the terms of any
        one or more Stock Awards; provided, however, that the rights under any Stock Award shall not be impaired by any such amendment unless (i) the Company requests the consent of the Participant and (ii) the
        Participant consents in writing.

       

      13.           Termination or Suspension of the Plan.

       

      
        
          (a)       Plan Term.  The Board may suspend or terminate the Plan at any time.  Unless sooner terminated,
              the Plan shall terminate on September 21, 2031.  No Stock Awards may be granted under the Plan while the Plan is suspended or after it is terminated.

           

            

        

      

      
        17

        
          

      

      (b)          No Impairment of Rights.  Suspension or termination of the Plan shall not impair rights and
        obligations under any Stock Award granted while the Plan is in effect except with the written consent of the Participant.

       

      14.           Effective Date of Plan.

       

      The Plan shall become effective as determined by the Board.

       

      15.           Choice of Law.

       

      The law of the State of New York shall govern all questions concerning the construction, validity and interpretation of this Plan, without regard to such state’s conflict of laws rules.

       

      
        18

        
          

      

      Attachment A

       

      Janel Corporation

      Amended and Restated 2017 Equity Incentive Plan

      Stock Option Agreement

      (Non-statutory Stock Option)

       

      Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, Janel Corporation (the “Company”) has granted you an option under its Amended and Restated 2017 Equity
        Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice.  Defined terms not explicitly defined in this Stock Option Agreement but
        defined in the Plan shall have the same definitions as in the Plan.

       

      The details of your option are as follows:

       

      1.            Vesting.  Subject to the limitations contained herein, your option will vest as provided in your
        Grant Notice, provided that vesting will cease upon the termination of your Continuous Service.

       

      2.            Number of Shares and Exercise Price.  The number of shares of Common Stock subject to your option
        and your exercise price per share referenced in your Grant Notice may be adjusted from time to time for Capitalization Adjustments.

       

      3.           Exercise prior to Vesting (“Early Exercise”).  If permitted in your Grant Notice (i.e., the “Exercise
        Schedule” indicates that “Early Exercise” of your option is permitted) and subject to the provisions of your option, you may elect at any time that is both (i) during the period of your Continuous Service and (ii) during the term of your option, to
        exercise all or part of your option, including the nonvested portion of your option; provided, however, that:

       

      (a)        a partial exercise of your option shall be deemed to cover first vested shares of Common Stock and then the earliest vesting installment of
        unvested shares of Common Stock;

       

      (b)         any shares of Common Stock so purchased from installments that have not vested as of the date of exercise shall be subject to the purchase
        option in favor of the Company as described in the Company’s form of Early Exercise Stock Purchase Agreement;

       

      (c)          you shall enter into the Company’s form of Early Exercise Stock Purchase Agreement with a vesting schedule that will result in the same
        vesting as if no early exercise had occurred; and

       

      4.           Method of Payment.  Payment of the exercise price is due in full upon exercise of all or any part of
        your option.  You may elect to make payment of the exercise price in cash or by check or in any other manner permitted by your Grant Notice.

       

      5.            Whole Shares.  You may exercise your option only for whole shares of Common Stock.

       

      
        
          

      

      
      6.           Securities Law Compliance.  Notwithstanding anything to the contrary contained herein, you may not
        exercise your option unless the shares of Common Stock issuable upon such exercise are then registered under the Securities Act or, if such shares of Common Stock are not then so registered, the Company has determined that such exercise and
        issuance would be exempt from the registration requirements of the Securities Act.  The exercise of your option also must comply with other applicable laws and regulations governing your option, and you may not exercise your option if the Company
        determines that such exercise would not be in material compliance with such laws and regulations.

       

      7.            Term.  You may not exercise your option before the commencement or after the expiration of its
        term.  The term of your option commences on the Date of Grant and expires upon the earliest of the following:

       

      (a)           three (3) months after the termination of your Continuous Service for any reason other than your Disability or death, provided that if during
        any part of such three (3) month period your option is not exercisable solely because of the condition set forth in Section 6, your option shall not expire until the earlier of the Expiration Date or until it shall have been exercisable for an
        aggregate period of three (3) months after the termination of your Continuous Service;

       

      (b)           twelve (12) months after the termination of your Continuous Service due to your Disability;

       

      (c)          eighteen (18) months after your death if you die either during your Continuous Service or within three (3) months after your Continuous
        Service terminates;

       

      (d)           the Expiration Date indicated in your Grant Notice; or

       

      (e)           the day before the tenth (10th) anniversary of the Date of Grant.

       

      8.          Exercise.

       

      (a)         You may exercise the vested portion of your option (and the unvested portion of your option if your Grant Notice so permits) during its term by
        delivering a Notice of Exercise (in a form designated by the Company) together with the exercise price to the Secretary of the Company, or to such other person as the Company may designate, during regular business hours, together with such
        additional documents as the Company may then require.

       

      (b)          By exercising your option you agree that, as a condition to any exercise of your option, the Company may require you to enter into an
        arrangement providing for the payment by you to the Company of any tax withholding obligation of the Company arising by reason of (1) the exercise of your option, (2) the lapse of any substantial risk of forfeiture to which the shares of Common
        Stock are subject at the time of exercise, or (3) the disposition of shares of Common Stock acquired upon such exercise.

       

      (c)          By exercising your option agree to execute and deliver such other agreements as may be reasonably requested by the Company and/or the
        underwriter(s) that are consistent with the foregoing or that are necessary to give further effect thereto.  In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to your shares of Common Stock
        until the end of such period.

       

      
        A-2

        
          

      

      9.          Transferability.  Your option is not transferable, except by will or by the laws of descent and
        distribution, and is exercisable during your life only by you.  Notwithstanding the foregoing, by delivering written notice to the Company, in a form satisfactory to the Company, you may designate a third party who, in the event of your death,
        shall thereafter be entitled to exercise your option.

       

      10.          Change In Control.

       

      (a)           If a Change in Control occurs and as of the effective time of such Change in Control your Continuous Service terminates due to an involuntary
        termination (not including death or Disability) without Cause or due to a voluntary termination with Good Reason, then, as of the date of termination of Continuous Service, the vesting and exercisability of your option shall be accelerated in full.

       

      (b)        “Cause” means the occurrence of any one or more of the following:  (i) your commission of any crime involving fraud, dishonesty or moral
        turpitude; (ii) your attempted commission of or participation in a fraud or act of dishonesty against the Company that results in (or might have reasonably resulted in) material harm to the business of the Company; (iii) your intentional, material
        violation of any contract or agreement between you and the Company or any statutory duty you owe to the Company; or (iv) your conduct that constitutes gross insubordination, incompetence or habitual neglect of duties and that results in (or might
        have reasonably resulted in) material harm to the business of the Company; provided, however, that the action or conduct described in clauses (iii) and (iv) above will constitute “Cause” only if such action
        or conduct continues after the Company has provided you with written notice thereof and thirty (30) days to cure the same.

       

      (c)          “Good Reason” means that one or more of the following are undertaken by the Company without your express written consent:  (i) the assignment
        to you of any duties or responsibilities that results in a material diminution in your function as in effect immediately prior to the effective date of the Change in Control; provided, however, that a
        change in your title or reporting relationships shall not provide the basis for a voluntary termination with Good Reason; (ii) a material reduction by the Company in your annual base salary, as in effect on the effective date of the Change in
        Control or as increased thereafter; provided, however, that Good Reason shall not be deemed to have occurred in the event of a reduction in your annual base salary that is pursuant to a salary reduction
        program affecting substantially all of the employees of the Company and that does not adversely affect you to a greater extent than other similarly situated employees; (iii) any failure by the Company to continue in effect any benefit plan or
        program, including incentive plans or plans with respect to the receipt of securities of the Company, in which you were participating immediately prior to the effective date of the Change in Control (hereinafter referred to as “Benefit Plans”), or
        the taking of any action by the Company that would adversely affect your participation in or reduce your benefits under the Benefit Plans or deprive you of any fringe benefit that you enjoyed immediately prior to the effective date of the Change in
        Control; provided, however, that Good Reason shall not be deemed to have occurred if the Company provides for your participation in benefit plans and programs that, taken as a whole, are comparable to the
        Benefit Plans; (iv) a relocation of your business office to a location more than fifty (50) miles from the location at which you performed your duties as of the effective date of the Change in Control, except for required travel by you on the
        Company’s business to an extent substantially consistent with your business travel obligations prior to the effective date of the Change in Control; or (v) a material breach by the Company of any provision of the Plan or the Option Agreement or any
        other material agreement between you and the Company concerning the terms and conditions of your employment.

       

      
        A-3

        
          

      

      11.          Option not a Service Contract.  Your option is not an employment or service contract, and nothing in
        your option shall be deemed to create in any way whatsoever any obligation on your part to continue in the employ of the Company or an Affiliate, or of the Company or an Affiliate to continue your employment.  In addition, nothing in your option
        shall obligate the Company or an Affiliate, their respective stockholders, Boards of Directors, Officers or Employees to continue any relationship that you might have as a Director or Consultant for the Company or an Affiliate.

       

      12.           Withholding Obligations.

       

      (a)         At the time you exercise your option, in whole or in part, or at any time thereafter as requested by the Company, you hereby authorize
        withholding from payroll and any other amounts payable to you, and otherwise agree to make adequate provision for (including by means of a “cashless exercise” pursuant to a program developed under Regulation T as promulgated by the Federal Reserve
        Board to the extent permitted by the Company), any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company or an Affiliate, if any, which arise in connection with the exercise of your option.

       

      (b)        Upon your request and subject to approval by the Company, in its sole discretion, and compliance with any applicable legal conditions or
        restrictions, the Company may withhold from fully vested shares of Common Stock otherwise issuable to you upon the exercise of your option a number of whole shares of Common Stock having a Fair Market Value, determined by the Company as of the date
        of exercise, not in excess of the minimum amount of tax required to be withheld by law (or such lower amount as may be necessary to avoid variable award accounting).  If the date of determination of any tax withholding obligation is deferred to a
        date later than the date of exercise of your option, share withholding pursuant to the preceding sentence shall not be permitted unless you make a proper and timely election under Section 83(b) of the Code, covering the aggregate number of shares
        of Common Stock acquired upon such exercise with respect to which such determination is otherwise deferred, to accelerate the determination of such tax withholding obligation to the date of exercise of your option.  Notwithstanding the filing of
        such election, shares of Common Stock shall be withheld solely from fully vested shares of Common Stock determined as of the date of exercise of your option that are otherwise issuable to you upon such exercise.  Any adverse consequences to you
        arising in connection with such share withholding procedure shall be your sole responsibility.

       

      (c)        You may not exercise your option unless the tax withholding obligations of the Company and/or any Affiliate are satisfied.  Accordingly, you may
        not be able to exercise your option when desired even though your option is vested, and the Company shall have no obligation to issue a certificate for such shares of Common Stock or release such shares of Common Stock from any escrow provided for
        herein unless such obligations are satisfied.

       

      

      
        A-4

        
          

      

      13.          Notices.  Any notices provided for in your option or the Plan shall be given in writing and shall be
        deemed effectively given upon receipt or, in the case of notices delivered by mail by the Company to you, five (5) days after deposit in the United States mail, postage prepaid, addressed to you at the last address you provided to the Company.

       

      14.          Governing Plan Document.  Your option is subject to all the provisions of the Plan, the provisions of
        which are hereby made a part of your option, and is further subject to all interpretations, amendments, rules and regulations, which may from time to time be promulgated and adopted pursuant to the Plan.  In the event of any conflict between the
        provisions of your option and those of the Plan, the provisions of the Plan shall control.

       

      
        A-5

        
          

      

      Attachment B

       

      Janel Corporation

      Stock Option Grant Notice

      (Amended and Restated 2017 Equity Incentive Plan)

       

      Janel Corporation (the “Company”), pursuant to its Amended and Restated 2017 Equity Incentive Plan (the “Plan”), hereby grants to Optionholder an option to purchase the number of shares of the Company’s Common Stock
        set forth below.  This option is subject to all of the terms and conditions as set forth herein and in the Stock Option Agreement, the Plan and the Notice of Exercise, all of which are attached hereto and incorporated herein in their entirety.

       

      	
              Optionholder:

            	 
	
              Date of Grant:

            	 
	
              Vesting Commencement Date:

            	 
	
              Number of Shares Subject to Option:

            	 
	
              Exercise Price (Per Share):

            	 
	
              Total Exercise Price:

            	 
	
              Expiration Date:

            	 

      

      

      Type of Grant:  ☐  Non-statutory Stock Option

       

      Exercise Schedule:  ☐  Same as Vesting Schedule  ☐  Early Exercise Permitted

       

      Vesting Schedule:

       

      Payment:  By one or a combination of the following items (described in the Stock Option Agreement):

       

      ☐  By cash or check

       

      ☐  Pursuant to a Regulation T Program if the Shares are publicly traded

       

      ☐  By delivery of already-owned shares if the Shares are publicly traded

       

      Additional Terms/Acknowledgements: The undersigned Optionholder acknowledges receipt of, and understands and agrees to, this Stock Option Grant Notice, the Stock Option Agreement and the Plan.  Optionholder further acknowledges that as of the Date of
          Grant, this Stock Option Grant Notice, the Stock Option Agreement and the Plan set forth the entire understanding between Optionholder and the Company regarding the acquisition of stock in the Company and supersede all prior oral and written
          agreements on that subject with the exception of (i) options previously granted and delivered to Optionholder under the Plan, and (ii) the following agreements only:

       

      	
              Other Agreements:

            	 

      

      

      
        
          

      

      
      	
              Janel Corporation

            	 	
              Optionholder:

            
	 	 	 
	
              By:

            	 	 	 	 
	 	
              Signature

            	 	 	
              Signature

            
	
              Title:

            	 	 	
              Date:

            	 
	
              Date:

            	 	 	 	 

      

      

      Attachments:  Stock Option Agreement, Amended and Restated 2017 Equity Incentive Plan and Notice of Exercise

       

        

      
        B-2

        
          

      

      Attachment C

       

      NOTICE OF EXERCISE

       

      TO:  Janel Corporation

       

      Date of Exercise: _______________

       

      Ladies and Gentlemen:

       

      This constitutes notice under my stock option that I elect to purchase the number of shares for the price set forth below.

       

      	
              Stock option dated:

            	 
	
              Number of shares as to which option is exercised:

            	 
	
              Certificates to be issued in name of:

            	 
	
              Total exercise price:

            	
              $

            
	
              Cash payment delivered herewith:

            	
              $

            
	
              Value of ________ shares of common stock delivered herewith1:

            	
              $

            

      

      

      By this exercise, I agree (i) to provide such additional documents as you may require pursuant to the terms of the Amended and Restated 2017 Equity Incentive Plan and (ii) to provide for the
        payment by me to you (in the manner designated by you) of your withholding obligation, if any, relating to the exercise of this option.

       

      I hereby make the following certifications and representations with respect to the number of shares of Common Stock of the Company listed above (the “Shares”), which are being acquired by me for my
        own account upon exercise of the Option as set forth above:

       

      	 	
              Very truly yours,

            
	 	 
	 	 	 

      

      

      

      
        	
                1

              	
                Shares must meet the public trading requirements set forth in the option.  Shares must be valued in accordance with the terms of the option being exercised, must have been owned for the minimum period
                  required in the option, and must be owned free and clear of any liens, claims, encumbrances or security interests.  Certificates must be endorsed or accompanied by an executed assignment separate from certificate.Exhibit 4.1

 

WARRANT AGREEMENT

 

This Warrant Agreement (“Warrant
Agreement”) is made as of December 21, 2021, by and between Gardiner Healthcare Acquisitions Corp., a Delaware corporation (the
 “Company”), and Continental Stock Transfer & Trust Company (the “Warrant Agent”).

 

WHEREAS, the Company is engaged
in a public offering (the “Public Offering”) of 7,500,000 units (the “Units”) of the Company (and
up to 1,125,000 additional Units if the underwriters’ over-allotment option is exercised in full), each Unit consisting of one share
of common stock, par value $0.0001 per share (the “Common Stock”) and one warrant (the “Public Warrant”
or “Public Warrants”), each Public Warrant entitling its holder to purchase one share of Common Stock (the “Public
Warrant Shares”);

 

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-1,
File No. 333- 260422 (“Registration Statement”), and a prospectus (the “Prospectus”), for the registration,
under the Securities Act of 1933, as amended (“Securities Act”), of, among other securities, the Public Warrants;

 

WHEREAS, the Company has received
a binding commitment from Gardiner Healthcare Holdings, LLC to purchase up to 3,632,813warrants, Chardan Gardiner LLC to purchase up to
622,768 warrants, and CCMAUS Pty Ltd. to purchase up to 588,170warrants pursuant to the Private Placement Warrants Purchase Agreements,
dated as of [•], 2021 (collectively, the “Private Placement Warrants Purchase Agreements”), and in connection
therewith, will issue and deliver up to 4,843,750warrants (the “Private Warrants”), each whole Private Warrant entitling
its holder to purchase one share of Common Stock (“Private Warrant Shares”, and together with the Public Warrant Shares,
the “Warrant Shares”);

 

WHEREAS,
the Company may issue up to an additional 1,500,000 redeemable warrants in satisfaction of certain working capital loans made by the Company’s
officers, directors, initial stockholders (as defined in the Prospectus) and their affiliates (“Working Capital Warrants”);

 

WHEREAS,
following consummation of the Public Offering, the Company may issue additional warrants (“Post IPO Warrants” and collectively
with the Public Warrants, Private Warrants and Working Capital Warrants, the “Warrants”) in connection with, or following
the consummation by the Company of, an initial business combination;

 

WHEREAS, the Company desires
the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration,
transfer, exchange, redemption and exercise of the Warrants;

 

WHEREAS, the Company desires
to provide for the form, terms and provisions of the Warrants, including the terms upon which they shall be issued and exercised, and
the respective rights, limitation of rights and immunities of the Company, the Warrant Agent and the holders of the Warrants; and

 

WHEREAS, all acts and things
have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or
on behalf of the Warrant Agent, as provided herein, the legally valid and binding obligations of the Company, and to authorize the execution
and delivery of this Warrant Agreement.

 

    

     

    

 

NOW, THEREFORE, in consideration
of the mutual agreements herein contained, the parties hereto agree as follows:

 

1.             
Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the
Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions
set forth in this Warrant Agreement.

 

2.             
Warrants.

 

2.1          
Form of Warrant. Each Warrant other than a Private Warrant shall be: (a) issued in registered form only, (b) in substantially
the form of Exhibit A hereto, the provisions of which are incorporated herein and (c) signed by, or bear the facsimile signature
of (i) the Chairman of the Board, the Chief Executive Officer, the President or a Vice President and (ii) the Chief Financial Officer,
Treasurer, an Assistant Treasurer, the Secretary or an Assistant Secretary of the Company. In the event the person whose facsimile signature
has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant
is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance.

 

2.2          
Effect of Countersignature. Unless and until countersigned by the Warrant Agent pursuant to this Warrant Agreement,
a Warrant shall be invalid and of no effect and may not be exercised by the holder thereof.

 

2.3           Registration.

 

2.3.1        
Warrant Register. The Warrant Agent shall maintain books (the “Warrant Register”), for the registration
of the original issuance and transfers of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register
the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions delivered
to the Warrant Agent by the Company.

 

2.3.2        
Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant
Agent may deem and treat the person in whose name such Warrant shall be registered upon the Warrant Register (“Registered Holder”)
as the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other writing
on the Warrant certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for
all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

 

2.4           Detachability of Warrants. Each of the securities comprising the Units will begin to trade separately on (i) the
90th day after the effectiveness of the Registration Statement, or (ii) such earlier date as Chardan Capital Markets, LLC, as representative
of the underwriters (the “Representative”), shall determine is acceptable (such date, the “Detachment Date”).
In no event will separate trading of the securities comprising the Units commence until the Company (i) files a Current Report on Form
8-K with the SEC including audited balance sheet reflecting the Company’s receipt of the gross proceeds of the Public Offering and
(ii) issues a press release announcing when such separate trading will begin.

 

    

     

    

 

2.5           Private Warrants. The Private Warrants (i) will be exercisable either for cash or on a cashless basis at the holder’s
option pursuant to Section 3.3 hereof and (ii) will not be redeemable by the Company, in either case as long as the Private Warrants
are held by the initial purchasers or any of their permitted transferees (as prescribed in the Private Placement Warrants Purchase Agreements).
The Private Warrants may not be sold, transferred, assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative,
put, or call transaction that would result in the effective economic disposition of, the Private Warrants (or any securities underlying
the Private Warrants) for a period of one hundred eighty (180) days following the effective date of the Registration Statement to anyone
other than any underwriter and selected dealer participating in the Public Offering and the officers or partners thereof, if all securities
so transferred remain subject to the lock-up restriction set forth above for the remainder of the time period.

 

3.             Terms and Exercise of Warrants.

 

3.1         
Warrant Price. Each Warrant shall, when countersigned by the Warrant Agent, entitle the Registered Holder thereof,
subject to the provisions of such Warrant and of this Warrant Agreement, to purchase from the Company the number of shares of Common Stock
stated therein, at $11.50 per full share, subject to the adjustments provided in Section 4 hereof. The term “Warrant Price”
as used in this Warrant Agreement refers to the price per whole share at which shares of Common Stock may be purchased at the time such
Warrant is exercised. The Public Warrants may only be exercised for a whole number of Warrant Shares by a Registered Holder. The Company
in its sole discretion may lower the Warrant Price (including by allowing “cashless exercise”) at any time prior to the Expiration
Date (as defined below) for a period of not less than twenty (20) business days, provided, that the Company shall provide at least three
(3) days prior written notice of such reduction to Registered Holders of the Warrants and, provided further that any such reduction shall
be identical among all of the Warrants.

 

    

     

    

 

3.2          
Duration of Warrants. A Warrant may be exercised only during the period (“Exercise Period”) commencing
on the later to occur of (i) the completion of the Company’s initial business combination and (ii) 12 months following the closing
of the Public Offering, and terminating at 5:00 p.m., New York City time, on the earlier to occur of (i) (A) five years following the
completion of the Company’s initial business combination, other than the Private Warrants purchased by Chardan Gardiner LLC, and
(B) five years from the effective date of the Registration Statement with respect to the Private Warrants purchased by Chardan Gardiner
LLC, provided that once the Private Warrants are not beneficially owned by Chardan Gardiner LLC or any of its related persons anymore,
the Private Warrants may not be exercised five years following the completion of the Company’s initial business combination, and
(ii) the date fixed for redemption of the Warrants as provided in Section 6 of this Warrant Agreement (“Expiration Date”).
Except with respect to the right to receive the Redemption Price (as set forth in Section 6 hereunder), each Warrant not exercised on
or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Warrant Agreement
shall cease at the close of business on the Expiration Date. The Company may extend the duration of the Warrants by delaying the Expiration
Date; provided, however, that the Company will provide written notice of not less than 10 days to Registered Holders of such extension
and that such extension shall be identical in duration among all of the then outstanding Warrants. Notwithstanding the above, the Private
Warrants (and the Private Warrant Shares that are issuable upon exercise of the Private Warrants) to be purchased by Chardan Gardiner
LLC have been deemed compensation by Financial Industry Regulatory Authority, Inc. (“FINRA”) and are therefore subject to
a 180-day lock-up described in the following sentence pursuant to FINRA Rule 5110(e)(1) commencing on the effective date of the Registration
Statement as long as Chardan Capital Markets, LLC or any of its related persons beneficially own these Private Warrants. Pursuant to FINRA
Rule 5110(e)(1), the Private Warrants (and the Private Warrant Shares that are issuable upon exercise of the Private Warrants) purchased
by Chardan Gardiner LLC will not be sold during the Public Offering, or sold, transferred, assigned, pledged, or hypothecated, or be the
subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of such securities
by any person for a period of 180 days immediately following the effective date of the Registration Statement, except to any underwriter
and selected dealer participating in the Public Offering made pursuant to the Registration Statement and their bona fide officers or partners,
provided that all such securities so transferred remain subject to the lockup restriction above for the remainder of the time period.

 

3.3           Exercise of Warrants.

 

3.3.1          Cash Exercise. Subject to the provisions of the Warrant and this Warrant Agreement, a Warrant, when countersigned
by the Company, may be exercised by the Registered Holder thereof by surrendering it at the office of the Warrant Agent, or at the office
of its successor as Warrant Agent, currently being:

 

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, New York 10004

Attn: Compliance Department

 

with the subscription form, as set forth in the
Warrant, duly executed, and by paying in full, in lawful money of the United States, by certified or bank cashier’s check payable
to the order of the Warrant Agent or by wire transfer to the Warrant Agent’s bank account, the Warrant Price for each whole Warrant
Share as to which the Warrant is exercised and any and all applicable taxes due in connection with the exercise of the Warrant, the exchange
of the Warrant for the Warrant Shares, and the issuance of the Warrant Shares (such exercise, a “Cash Exercise”). A
Cash Exercise in accordance with this Section 3.3.1 is available to the Registered Holder only during such times that there is an effective
registration statement registering the Warrant Shares, with the prospectus contained therein being available for the resale of the Warrant
Shares.

 

     

     

    

 

3.3.2        
Cashless Exercise. Subject to Section 2.4, notwithstanding anything contained herein to the contrary, if there is
no effective registration statement registering the Warrant Shares on any day the Registered Holder desires to exercise the Warrants and
more than 120 days have passed since the Company completed its initial business combination, the Registered Holder may exercise the Warrants
in whole or in part in lieu of making a cash payment for whole numbers of Warrant Shares, by providing notice to the Chief Financial Officer
of the Company in a subscription form of its election to utilize cashless exercise, in which event the Company shall issue to the holder
the number of Warrant Shares determined as follows:

 

X = Y [(A-B)/A]

where:

 

X = the number of Warrant Shares to be issued to the holder.

Y = the number of Warrant Shares with respect to which this
Warrant is being exercised.

A = the fair market value of one share of Common Stock.

B = the Warrant Price.

 

The Registered Holder may not exercise any Warrants
in the absence of a registration statement except pursuant to this Section 3.3.2. For purposes of this Section 3.3.2 and
Section 4.1, the fair market value of one share of Common Stock is defined as follows:

 

		(i)	if the Company’s shares of Common Stock are listed and traded on the New York Stock Exchange, the
NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market (each, a “Trading Market”),
the fair market value shall be deemed the average reported last sale price of the shares of Common Stock on such Trading Market for the
10 trading days ending on the day prior to the date the subscription form is submitted to the Company in connection with the exercise
of the Warrant; or

 

		(ii)	if the Company’s shares of Common Stock are not listed on a Trading Market, but is traded in the
over-the-counter market, the fair market value shall be deemed to be the average of the bid price on such Trading Market for the 10 trading
days ending on the day prior to the date the subscription form is submitted in connection with the exercise of the Warrant; or

 

		(iii)	if there is no active public market for the Company’s shares of Common Stock, the fair market value
of the shares of Common Stock shall be determined in good faith by the Company’s board of directors.

 

3.3.3        Fractional Shares. Notwithstanding any provision to the contrary contained in this Warrant Agreement, the Company
shall not be required to issue any fraction of a Warrant Share in connection with the exercise of Warrants, and in any case where the
Registered Holder would be entitled under the terms of the Warrants to receive a fraction of a Warrant Share upon the exercise of such
Registered Holder’s Warrants, issue or cause to be issued only the largest whole number of Warrant Shares issuable on such exercise
(and such fraction of a Warrant Share will be disregarded); provided, that if more than one Warrant certificate is presented for exercise
at the same time by the same Registered Holder, the number of whole Warrant Shares which shall be issuable upon the exercise thereof shall
be computed on the basis of the aggregate number of Warrant Shares issuable on exercise of all such Warrants.

 

    

     

    

 

3.3.4        
Issuance of Certificates. No later than three (3) business days following the exercise of any Warrant and the clearance
of the funds in payment of the Warrant Price pursuant to Section 3.3.1 or cashless exercise pursuant to Section 3.3.2, the Company shall
issue, or cause to be issued, to the Registered Holder of such Warrant a certificate or certificates representing (or at the option of
the Registered Holder, deliver electronically through the facilities of the Depository Trust Corporation) the number of full shares of
Common Stock to which he, she or it is entitled, registered in such name or names as may be directed by him, her or it, and, if such Warrant
shall not have been exercised or surrendered in full, a new countersigned Warrant for the number of shares as to which such Warrant shall
not have been exercised or surrendered. Notwithstanding the foregoing, the Company shall not deliver, or cause to be delivered, any securities
without applicable restrictive legend pursuant to the exercise of a Warrant unless (a) a registration statement under the Securities Act
with respect to the shares of Common Stock issuable upon exercise of such Warrants is effective and a current prospectus relating to the
shares of Common Stock issuable upon exercise of the Warrants is available for delivery to the Registered Holder of the Warrant or (b)
in the opinion of counsel to the Company, the exercise of the Warrants is exempt from the registration requirements of the Securities
Act and such securities are qualified for sale or exempt from qualification under applicable securities laws of the states or other jurisdictions
in which the Registered Holder resides. Warrants may not be exercised by, or securities issued to, any Registered Holder in any state
in which such exercise or issuance would be unlawful. In addition, in no event will the Company be obligated to pay such Registered Holder
any cash consideration upon exercise or otherwise “net cash settle” the Warrant.

 

3.3.5        
Valid Issuance. All shares of Common Stock issued upon the proper exercise or surrender of a Warrant in conformity
with this Warrant Agreement shall be validly issued, fully paid and non-assessable.

 

3.3.6        
Date of Issuance. Each person or entity in whose name any such certificate for shares of Common Stock is issued shall,
for all purposes, be deemed to have become the holder of record of such shares on the date on which the Warrant was surrendered and payment
of the Warrant Price was made, irrespective of the date of delivery of such certificate, except that, if the date of such surrender and
payment is a date when the stock transfer books of the Company are closed, such person shall be deemed to have become the holder of such
shares at the close of business on the next succeeding date on which the stock transfer books are open.

 

    

     

    

 

3.3.7         
Maximum Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject
to the provisions contained in this subsection 3.3.7; however, no holder of a Warrant shall be subject to this subsection 3.3.7 unless
he, she or it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s
Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such
person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess
of 4.99% or 9.99% (or such other amount as such person may specify) (each, a “Maximum Percentage”) of the shares of
Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number
of shares of Common Stock beneficially owned by such person and its affiliates shall include the number of shares of Common Stock issuable
upon exercise of the Warrant with respect to which the determination of such sentence is being made, but shall exclude the shares of Common
Stock that would be issuable upon (x) exercise of the remaining, unexercised portion of the Warrant beneficially owned by such person
and its affiliates and (y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially
owned by such person and its affiliates (including, without limitation, any convertible notes or convertible preferred shares or warrants)
subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence,
for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the number of outstanding shares
of Common Stock, the holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company’s most
recent annual report on Form 10-K, quarterly report on Form 10-Q, current report on Form 8-K or other public filing with the SEC as the
case may be, (2) a more recent public announcement by the Company, or (3) any other notice by the Company or the Warrant Agent setting
forth the number of shares of Common Stock outstanding. For any reason at any time, upon the written request of the holder of the Warrant,
the Company shall, within two (2) business days, confirm orally and in writing to such holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or
exercise of equity securities of the Company by the holder and its affiliates since the date as of which such number of outstanding shares
of Common Stock was reported. By written notice to the Company, the holder of a Warrant may from time to time increase or decrease the
Maximum Percentage applicable to such holder to any other percentage specified in such notice; provided, however, that any such increase
shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company.

 

4.             Adjustments.

 

4.1          
Stock Dividends, Splits. If, after the date hereof, and subject to the provisions of Section 4.5 below, the number
of outstanding shares of Common Stock is increased by a stock dividend payable in shares of Common Stock, or by a forward or reverse split
of shares of Common Stock, or other similar event, then, on the effective date of such stock dividend, split or similar event, the number
of shares of Common Stock issuable on exercise of each Warrant shall be increased or decreased in proportion to such increase or decrease
in outstanding shares of Common Stock. A rights offering to all holders of the shares of Common Stock entitling holders to purchase shares
of Common Stock at a price less than the fair market value shall be deemed a stock dividend of a number of shares of Common Stock equal
to the product of (i) the number of shares of Common Stock actually sold in such rights offering (or issuable under any other equity securities
sold in such rights offering that are convertible into or exercisable for the shares of Common Stock) multiplied by (ii) one (1) minus
the quotient of (x) the price per share of Common Stock paid in such rights offering divided by (y) the fair market value. For purposes
of this subsection 4.1, if the rights offering is for securities convertible into or exercisable for shares of Common Stock, in determining
the price payable for the shares of Common Stock, there shall be taken into account any consideration received for such rights, as well
as any additional amount payable upon exercise or conversion.

 

4.2          
Aggregation of Shares. If, after the date hereof, and subject to the provisions of Section 4.6, the number of outstanding
shares of Common Stock is decreased by a consolidation, combination or reclassification of shares of Common Stock or other similar event,
then, on the effective date of such consolidation, combination, reclassification or similar event, the number of shares of Common Stock
issuable on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding shares of Common Stock.

 

    

     

    

 

4.3           Extraordinary Dividends. If the Company, at any time while the Warrants (or rights to purchase the Warrants) are
outstanding and unexpired, shall pay a dividend or make a distribution in cash, securities or other assets to the holders of the shares
of Common Stock on account of such shares of Common Stock (or other shares of the Company’s capital stock into which the Warrants
are convertible), other than (a) as described in subsection 4.1 above, (b) Ordinary Cash Dividends (as defined below), (c) to satisfy
the conversion rights of the holders of the shares of Common Stock in connection with a proposed initial business combination or vote
to extend the time period to complete an initial business combination, (d) as a result of the repurchase of shares of Common Stock by
the Company in connection with an initial business combination or as otherwise permitted by the Investment Management Trust Agreement
between the Company and the Warrant Agent dated of even date herewith or (e) in connection with the Company’s liquidation and the
distribution of its assets upon its failure to consummate a business combination (any such non-excluded event being referred to herein
as an “Extraordinary Dividend”), then the Warrant Price shall be decreased, effective immediately after the effective date
of such Extraordinary Dividend, by the amount of cash and the fair market value (as determined by the Company’s board of directors,
in good faith) of any securities or other assets paid on each share of Common Stock in respect of such Extraordinary Dividend. For purposes
of this subsection 4.3, “Ordinary Cash Dividends” means any cash dividend or cash distribution which, when combined on a per
share basis with the per share amounts of all other cash dividends and cash distributions paid on the shares of Common Stock during the
365-day period ending on the date of declaration of such dividend or distribution (as adjusted to appropriately reflect any of the events
referred to in other subsections of this Section 4 and excluding cash dividends or cash distributions that resulted in an adjustment to
the Warrant Price or to the number of shares of Common Stock issuable on exercise of each Warrant) does not exceed $0.50 (being 5% of
the offering price of the Units in the Public Offering).

 

4.4          
Adjustments in Exercise Price.

 

4.4.1      Whenever the number of shares of Common Stock purchasable upon the exercise of the Warrants is adjusted, as provided in
Sections 4.1 and 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price, immediately prior
to such adjustment, by a fraction, (a) the numerator of which shall be the number of shares of Common Stock purchasable upon the exercise
of the Warrants immediately prior to such adjustment, and (b) the denominator of which shall be the number of shares of Common Stock so
purchasable immediately thereafter.

 

4.4.2      If (i) the Company issues additional shares of Common Stock or equity-linked securities for capital raising purposes in
connection with the closing of its initial business combination at an issue price or effective issue price of less than $9.20 per share
of Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors
and, in the case of any such issuance to the Company’s initial stockholders or their affiliates, without taking into account any
founder shares (as defined in the Prospectus) or Private Warrants held by them, as applicable, prior to such issuance) (the “newly
issued price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest
thereon, available for the funding of the Company’s initial business combination on the date of the completion of its initial business
combination (net of redemptions), and (z) the volume-weighted average trading price of the Common Stock during the 20 trading day period
starting on the trading day prior to the day on which the Company completes its initial business combination (such price, the “Market
Value”) is below $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115%
of the higher of the Market Value and the newly issued price and the $16.50 per share redemption trigger price will be adjusted (to the
nearest cent) to be equal to 165% of the higher of the Market Value and the newly issued price.

 

    

     

    

 

4.5           Replacement
of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding shares of Common Stock
(other than a change covered by Sections 4.1, 4.2 or 4.3 hereof or one that solely affects the par value of such shares of Common Stock),
or, in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger
in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding
shares of Common Stock), or, in the case of any sale or conveyance to another corporation or entity of the assets or other property of
the Company as an entirety or substantially as an entirety, in connection with which the Company is dissolved, the Registered Holders
shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and
in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights
represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification,
reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the Registered Holder would
have received if such Registered Holder had exercised his, her or its Warrant(s) immediately prior to such event; and if any reclassification
or reorganization also results in a change in shares of Common Stock covered by Sections 4.1, 4.2 or 4.3, then such adjustment shall
be made pursuant to Sections 4.1, 4.2, 4.3 and this Section 4.5. The provisions of this Section 4.5 shall similarly apply to successive
reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event will the Warrant Price be reduced
to less than the par value per share issuable upon exercise of the Warrants.

 

4.6           Notices
of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares issuable upon exercise of a Warrant, the
Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment
and the increase or decrease, if any, in the number of shares purchasable at such price upon the exercise of a Warrant, setting forth
in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event specified
in Sections 4.1 – 4.5 the Company shall give written notice to each Registered Holder, at the last address set forth for
such Registered Holder in the Warrant Register, of the record date or the effective date of the event. Failure to give such notice, or
any defect therein, shall not affect the legality or validity of such event.

 

4.7           Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and
Warrants issued after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants initially
issued pursuant to this Warrant Agreement. However, the Company may, at any time, in its sole discretion, make any change in the form
of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or
countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

 

    

     

    

 

4.8           Notice of Certain Transactions. In the event that the Company shall (a) offer to holders of all its shares of Common
Stock rights to subscribe for or to purchase any securities convertible into shares of Common Stock or shares of stock of any class or
any other securities, rights or options, (b) issue any rights, options or warrants entitling all the holders of shares of Common Stock
to subscribe for shares of Common Stock, or (c) make a tender offer, redemption offer or exchange offer with respect to the shares of
Common Stock, the Company shall send to the Registered Holders a notice of such action or offer. Such notice shall be mailed to the Registered
Holders at their addresses as they appear in the Warrant Register, which shall specify the record date for the purposes of such dividend,
distribution or rights, or the date such issuance or event is to take place and the date of participation therein by the holders of shares
of Common Stock, if any such date is to be fixed, and shall briefly indicate the effect of such action on the shares of Common Stock and
on the number and kind of any other shares of stock and on other property, if any, and the number of shares of Common Stock and other
property, if any, issuable upon exercise of each Warrant and the Warrant Price after giving effect to any adjustment pursuant to this
Section 4 which would be required as a result of such action. Such notice shall be given as promptly as practicable after the Company
has taken any such action.

 

5.              Transfer and Exchange of Warrants.

 

5.1           Transfer
of Warrants. Prior to the Detachment Date, the Warrants may be transferred or exchanged only together with the Unit in which such
Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange of such Unit. Furthermore,
each transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants included in such Unit. From
and after the Detachment Date, this Section 5.1 will have no further force and effect.

 

5.2           Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant
into the Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied
by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall
be issued and the old Warrant shall be cancelled by the Warrant Agent. The Warrants so cancelled shall be delivered by the Warrant Agent
to the Company from time to time upon the Company’s request.

 

5.3           Procedure
for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or transfer,
and, thereupon, the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of
the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that, in the event a Warrant surrendered
for transfer bears a restrictive legend, the Warrant Agent shall not cancel such Warrant and shall issue new Warrants in exchange therefor
until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether
the new Warrants must also bear a restrictive legend.

 

    

     

    

 

5.4           Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which
will result in the issuance of a warrant certificate for a fraction of a warrant.

 

5.5           Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

 

5.6          
Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in
accordance with the terms of this Warrant Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5,
and the Company, whenever required by the Warrant Agent, will supply the Warrant Agent with Warrants duly executed on behalf of the Company
for such purpose.

 

6.              Redemption.

 

6.1           Redemption. All (and not less than all) of the outstanding Warrants may be redeemed, in whole and not in part, at
the option of the Company, at any time from and after the Warrants become exercisable, and prior to their expiration, at the office of
the Warrant Agent, upon the notice referred to in Section 6.2, at the price of $0.01 per Warrant (“Redemption Price”);
provided that the last sales price of the shares of Common Stock has been equal to or greater than $16.50 per share (subject to adjustment
for splits, dividends, recapitalizations and other similar events), for any twenty (20) trading days within a thirty (30) trading day
period ending on the third business day prior to the date on which notice of redemption is given and provided further that there is a
current registration statement in effect with respect to the shares of Common Stock underlying the Warrants for each day in the aforementioned
30-day trading period and continuing each day thereafter until the Redemption Date (defined below). For avoidance of doubt, if and when
the warrants become redeemable by the Company under this Section 6.1, the Company may exercise its redemption right, even if it is unable
to register or qualify the Warrant Shares for sale under all applicable state securities laws.

 

6.2           Date Fixed for, and Notice of, Redemption. In the event the Company shall elect to redeem all of the Warrants, the
Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall be mailed by first
class mail, postage prepaid, by the Company not less than 30 days prior to the date fixed for redemption to the Registered Holders of
the Warrants to be redeemed at their last addresses as they shall appear on the Warrant Register. Any notice mailed in the manner herein
provided shall be conclusively presumed to have been duly given, whether or not the Registered Holder received such notice.

 

6.3           Exercise
After Notice of Redemption. The Warrants may be exercised in accordance with Section 3 of this Warrant Agreement at any time after
notice of redemption shall have been given by the Company pursuant to Section 6.2 hereof and prior to the Redemption Date; provided that
the Company may require the Registered Holder who desires to exercise the Warrant to elect cashless exercise as set forth under Section
3.3.2, and such Registered Holder must exercise the Warrants on a cashless basis if the Company so requires. On and after the Redemption
Date, the Registered Holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants, the Redemption
Price.

 

    

     

    

 

6.4           No
Other Rights to Cash Payment. Except for a redemption in accordance with this Section 6, no Registered Holder of any Warrant shall
be entitled to any cash payment whatsoever from the Company in connection with the ownership, exercise or surrender of any Warrant under
this Warrant Agreement.

 

7.             
Other Provisions Relating to Rights of Registered Holders of Warrants.

 

7.1           No
Rights as Stockholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder of the Company,
including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent
or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other
matter.

 

7.2           Lost, Stolen Mutilated or Destroyed Warrants. If any Warrant is lost, stolen, mutilated or destroyed, the Company
and the Warrant Agent may, on such terms as to indemnity or otherwise as they may in their discretion impose (which terms shall, in the
case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor and date as the Warrant so
lost, stolen, mutilated or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether
or not the allegedly lost, stolen, mutilated or destroyed Warrant shall be at any time enforceable by anyone.

 

7.3           Reservation of Shares of Common Stock. The Company shall at all times reserve and keep available a number of its
authorized but unissued shares of Common Stock that will be sufficient to permit the exercise in full of all outstanding Warrants issued
pursuant to this Warrant Agreement.

 

7.4           Registration
of Shares of Common Stock. The Company agrees that as soon as practicable after the closing of a business combination, it shall use
its best efforts to file with the SEC a registration statement for the registration under the Securities Act of the shares of Common
Stock issuable upon exercise of the Warrants, and to cause the same to become effective and to maintain the effectiveness of such registration
statement, and a current prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of this
Warrant Agreement. In addition, the Company agrees to use its best efforts to register the shares of Common Stock issuable upon exercise
of the Warrants under state blue sky laws, to the extent an exemption is not available.

 

8.              Concerning the Warrant Agent and Other Matters.

 

8.1           Payment of Taxes. The Company will, from time to time, promptly pay all taxes and charges that may be imposed upon
the Company or the Warrant Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of Warrants, but the
Company shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares.

 

    

     

    

 

8.2          
Resignation, Consolidation, or Merger of Warrant Agent.

 

8.2.1          Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign
its duties and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to
the Company. If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint,
in writing, a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period
of 30 days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the Registered Holder of
the Warrant (who shall, with such notice, submit his, her or its Warrant for inspection by the Company), then the Registered Holder of
any Warrant may apply to the Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant
Agent. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing under
the laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New
York, and be authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state
authorities. After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties
and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further
act or deed; but, if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the
expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor
Warrant Agent hereunder; and, upon request of any successor Warrant Agent, the Company shall make, execute, acknowledge, and deliver any
and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority,
powers, rights, immunities, duties and obligations.

 

8.2.2          Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give
notice thereof to the predecessor Warrant Agent and the transfer agent for the shares of Common Stock not later than the effective date
of any such appointment.

 

8.2.3          Merger or Consolidation of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which
it may be consolidated or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall
be the successor Warrant Agent under this Warrant Agreement without any further act on the part of the Company or the Warrant Agent.

 

8.3           Fees
and Expenses of Warrant Agent.

 

8.3.1          Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as Warrant Agent
hereunder and will reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution
of its duties hereunder.

 

8.3.2        
Further Assurances. The Company agrees to perform, execute, acknowledge and deliver, or cause to be performed, executed,
acknowledged and delivered, all such further and other acts, instruments and assurances as may reasonably be required by the Warrant Agent
for the carrying out or performing of the provisions of this Warrant Agreement.

 

    

     

    

 

8.4          
Liability of Warrant Agent.

 

8.4.1          Reliance on Company Statement. Whenever, in the performance of its duties under this Warrant Agreement, the Warrant
Agent shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering
any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to
be conclusively proved and established by a statement signed by the Chief Executive Officer, Chief Financial Officer or Chairman of the
Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered
in good faith by it pursuant to the provisions of this Warrant Agreement.

 

8.4.2          Indemnity. The Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad
faith. The Company agrees to indemnify the Warrant Agent and hold it harmless against any and all liabilities, including judgments, costs
and reasonable counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Warrant Agreement, except as a
result of the Warrant Agent’s gross negligence, willful misconduct or bad faith.

 

8.4.3          Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Warrant Agreement
or with respect to the validity or execution of any Warrant (except its countersignature thereof); nor shall it be responsible for any
breach by the Company of any covenant or condition contained in this Warrant Agreement or in any Warrant; nor shall it be responsible
to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method or amount of any such
adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it, by any act hereunder, be
deemed to make any representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant
to this Warrant Agreement or any Warrant or as to whether any shares of Common Stock will when issued be valid and fully paid and non-assessable.

 

8.5          Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Warrant Agreement and agrees
to perform the same upon the terms and conditions herein set forth and, among other things, shall account promptly to the Company with
respect to Warrants exercised and concurrently account for, and pay to the Company, all moneys received by the Warrant Agent for the purchase
of shares of the Company’s shares of Common Stock through the exercise of Warrants.

 

8.6          
Waiver. The Warrant Agent hereby waives any right of set-off or any other right, title, interest or claim of any
kind (“Claim”) in or to any distribution of the Trust Account (as defined in that certain Investment Management Trust Agreement,
dated as of the date hereof, by and between the Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse,
reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever.

 

9.            
Miscellaneous Provisions.

 

9.1           Successors.
All the covenants and provisions of this Warrant Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure
to the benefit of their respective successors and assigns.

 

    

     

    

 

9.2           Notices. Any notice, statement or demand authorized by this Warrant Agreement to be given or made by the Warrant
Agent or by the Registered Holder of any Warrant to or on the Company shall be delivered by hand or sent by registered or certified mail
or overnight courier service, addressed (until another address is filed in writing by the Company with the Warrant Agent) as follows:

 

Gardiner Healthcare Acquisitions Corp.

3107 Warrington Road

Shaker Heights, OH 44120

Attn: Chief Executive Officer

 

with a copy (which shall not constitute notice) to:

 

Reed Smith
LLP

506 Carnegie Center

Suite 300

Princeton, New Jersey
08540

Attn: Edward P.
Bromley III, Esq.

Email: ebromley@reedsmith.com

 

Any notice, statement or demand authorized by
this Warrant Agreement to be given or made by the Registered Holder of any Warrant or by the Company to or on the Warrant Agent shall
be delivered by hand or sent by registered or certified mail or overnight courier service, addressed (until another address is filed in
writing by the Warrant Agent with the Company), as follows:

 

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, New York 10004

 

Any notice, sent pursuant to this Warrant Agreement
shall be effective, if delivered by hand, upon receipt thereof by the party to whom it is addressed, if sent by overnight courier, on
the next business day of the delivery to the courier, and if sent by registered or certified mail on the third day after registration
or certification thereof.

 

9.3           Applicable Law. The validity, interpretation, and performance of this Warrant Agreement and of the Warrants shall
be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result
in the application of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against
it arising out of or relating in any way to this Warrant Agreement, including under the Securities Act, shall be brought and enforced
in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably submits
to such jurisdiction, which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. The Company hereby waives
any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing, the
provisions of this paragraph will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other
claim for which the federal district courts of the United States of America are the sole and exclusive forum. Any person or entity purchasing
or otherwise acquiring any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in
this Section 9.3. If any action, the subject matter of which is within the scope of the forum provisions above, is filed in a court other
than a court located within the State of New York or the United States District Court for the Southern District of New York (a “Foreign
Action”) in the name of any warrant holder, such warrant holder shall be deemed to have consented to: (x) the personal jurisdiction
of the state and federal courts located within the State of New York or the United States District Court for the Southern District of
New York in connection with any action brought in any such court to enforce the forum provisions (an “Enforcement Action”),
and (y) having service of process made upon such warrant holder in any Enforcement Action by service upon such warrant holder’s
counsel in the Foreign Action as agent for such warrant holder.

 

    

     

    

 

9.4           Persons Having Rights under this Warrant Agreement. Nothing in this Warrant Agreement expressed and nothing that
may be implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation
other than the parties hereto and the Registered Holders of the Warrants and, for the purposes of Sections 2.5 hereof, the Representative
and the underwriters, any right, remedy, or claim under or by reason of this Warrant Agreement or of any covenant, condition, stipulation,
promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Warrant Agreement shall
be for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the Registered Holders of the Warrants.

 

9.5           Examination of the Warrant Agreement. A copy of this Warrant Agreement shall be available at all reasonable times
at the office of the Warrant Agent in the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of
any Warrant. The Warrant Agent may require any such Registered Holder to submit his, her or its Warrant for inspection.

 

9.6           Counterparts-
Facsimile Signatures. This Warrant Agreement may be executed in any number of counterparts, and each of such counterparts shall,
for all purposes, be deemed to be an original, and all such counterparts shall together constitute one and the same instrument. Facsimile
signatures shall constitute original signatures for all purposes of this Warrant Agreement.

 

9.7           Effect
of Headings. The section headings herein are for convenience only and are not part of this Warrant Agreement and shall not affect
the interpretation thereof

 

9.8           Amendments. This Warrant Agreement and any Warrant certificate may be amended by the parties hereto by executing
a supplemental warrant agreement, without the consent of any of the Warrant holders, for the purpose of (i) curing any ambiguity, or curing,
correcting or supplementing any defective provision contained herein, or making any other provisions with respect to matters or questions
arising under this Warrant Agreement that is not inconsistent with the provisions of this Warrant Agreement or the Warrant certificates,
(ii) evidencing the succession of another corporation to the Company and the assumption by any such successor of the covenants of the
Company contained in this Warrant Agreement and the Warrants, (iii) evidencing and providing for the acceptance of appointment by a successor
Warrant Agent with respect to the Warrants, (iv) adding to the covenants of the Company for the benefit of the Registered Holders or surrendering
any right or power conferred upon the Company under this Warrant Agreement, or (viii) amending this Warrant Agreement and the Warrants
in any manner that the Company may deem to be necessary or desirable and that will not adversely affect the interests of the Registered
Holders in any material respect. All other modifications or amendments to this Warrant Agreement, including any amendment to increase
the Warrant Price or shorten the Exercise Period, shall require the written consent of the Registered Holders of a majority of the then
outstanding Warrants. Notwithstanding the foregoing, the Company may extend the duration of the Exercise Period in accordance with Section
3.2 without such consent.

 

9.9           Severability.
This Warrant Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect
the validity or enforceability of this Warrant Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid
or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Warrant Agreement a provision
as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

[SIGNATURE PAGE FOLLOWS]

 

    

     

    

 

IN WITNESS WHEREOF, this Warrant
Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

	 	GARDINER
    HEALTHCARE
	 	ACQUISITIONS
    CORP.
	 	 
	 	 
	 	By: 	/s/ Marc F. Pelletier 
	 	Name:	 Marc F. Pelletier
	 	Title:	 Chief Executive Officer
	 	 
	 	CONTINENTAL
    STOCK
	 	TRANSFER
    & TRUST COMPANY
	 	 
	 	 
	 	By:	 /s/ Erika Young
	 	Name:	 Erika Young
	 	Title: 	Vice President

 

[Signature Page to Warrant
Agreement]

 

    

     

    

 

Exhibit A

 

Form of Warrant

 

See attached.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]